How to Invest in the Coronavirus Vaccine Race Right Now
With 10 coronavirus vaccine programs in phase 3 trials, it's looking like the race to bring a safe and efficacious vaccine to market is nearing the finish line. Leaders of the pack, including Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE), may even apply for an Emergency Use Authorization (EUA) later this month. Just this Monday, Pfizer and partner BioNTech (NASDAQ: BNTX) announced positive interim phase 3 efficacy data, which showed their candidate was more than 90% effective at preventing COVID-19 infection. Does all of this mean it's too late to get in on the action or reinforce your positions in some of the vaccine race players? Not at all.
In fact, there are plenty of ways to invest in the coronavirus vaccine race right now -- and benefit well into the future. However, there are some factors to consider before getting started.
Image source: Getty Images.
Source Fool.com
